Liu, Y., Cricrì, M., He, J., Kai, J., Chen, X., Yu, C., Yuan, Y., Ding, K., Yang, Q. (2026). CONCEPT (combination of cetuximab plus fruquintinib treatment ± immunotherapy): A multicenter, randomized, open-label phase II trial in first-line pMMR RAS/BRAF wild-type unresectable metastatic colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3680